Cargando…
Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments
BACKGROUND: Treatment of solid tumors with vascular disrupting agent OXi4503 results in over 90% tumor destruction. However, a thin rim of viable cells persists in the tumor periphery following treatment, contributing to subsequent recurrence. This study investigates inherent differences in the micr...
Autores principales: | Nguyen, Linh, Fifis, Theodora, Malcontenti-Wilson, Caterina, Chan, Lie Sam, Costa, Patricia Nunes Luiza, Nikfarjam, Mehrdad, Muralidharan, Vijayaragavan, Christophi, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583184/ https://www.ncbi.nlm.nih.gov/pubmed/23153292 http://dx.doi.org/10.1186/1471-2407-12-522 |
Ejemplares similares
-
Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases
por: Lin, Wen Xu, et al.
Publicado: (2011) -
Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor
por: Fifis, Theodora, et al.
Publicado: (2013) -
Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis
por: Nguyen, Linh, et al.
Publicado: (2016) -
The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model
por: da Costa, Patricia Luiza Nunes, et al.
Publicado: (2018) -
Assessment of Liver Remnant Using ICG Clearance Intraoperatively during Vascular Exclusion: Early Experience with the ALIIVE Technique
por: Lau, Lawrence, et al.
Publicado: (2015)